Tom Holland: Endometriosis Diagnosis, Why Biomarkers Can’t Replace Imaging?
Tom Holland, Gynaecologist, robotic and advanced laparoscopic surgeon, endometriosis researcher at Guy’s and St Thomas’ NHS Foundation Trust, shared a post on LinkedIn:
“NICE met yesterday to evaluate non-invasive lab based tests for endometriosis diagnosis.
This is a good thing.
Anything that shortens the diagnostic wait and reduces surgical diagnosis deserves serious attention.
But here’s what the conversation often misses.
Even if a blood test or saliva test were 100% accurate, fully independently evaluated and cheaper than ultrasound, which they are not, there would still be a fundamental role for imaging.
Because a yes/ no diagnosis is only the beginning.
Before we can talk about treatment, we need to know:
Which organs are involved. Ovaries. Bowel. Bladder. Ureters.
How severe the disease is. Superficial peritoneal disease is a different surgical conversation to deep disease with bowel infiltration.
What the risks and benefits of the different treatments including surgery would be.
Whether surgery is even necessary.
A patient with ureteric or bowel stenosis needs a very different discussion to one without. Sometimes imaging changes the plan entirely.
What the effects on fertility are. For many patients, this is the question that matters most.
A positive biomarker test tells you something is there.
Imaging tells you what you’re dealing with.
Also if the spit test is negative what is causing the symptoms? Is it adenomyosis or fibroids or something else? High quality imaging is still useful even when the findings are normal.
Today’s NICE committee meeting is a step in the right direction.
The next step is making sure high quality imaging is available to all who need it.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
